Philip Morris (PM) Fertin Pharma Acquisition Accelerates Smoke Free Diversification - Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Pamela Kaufman reiterated an Overweight rating and $110.00 price target on Philip Morris (NYSE: PM) noting the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
